Introduction
C19H21N3O represents a molecular formula that corresponds to a compound containing nineteen carbon atoms, twenty‑one hydrogen atoms, three nitrogen atoms, and one oxygen atom. The empirical composition indicates that the molecule is likely to be aromatic, incorporating heteroaromatic rings or amine functionalities, and may possess a tertiary amine center. Such a structural motif is common in pharmacologically active agents, where nitrogen heterocycles provide binding interactions with biological targets, and the oxygen atom may function as a carbonyl or hydroxyl group. The formula also matches certain synthetic intermediates used in the preparation of more complex molecules. This article reviews the general characteristics, synthetic approaches, physicochemical properties, reactivity, and potential applications of compounds with this stoichiometry, drawing on established literature in organic chemistry and medicinal chemistry.
Molecular Structure
General Description
Compounds with the formula C19H21N3O are generally large, moderately non‑polar molecules that include at least one aromatic ring system. The presence of three nitrogen atoms suggests the inclusion of heteroaromatic rings such as pyridine, pyrimidine, or triazole, or aliphatic amine groups such as tertiary amines or secondary amides. The single oxygen atom is often incorporated as a carbonyl group within an amide, ester, or lactam, or as a hydroxyl group in an alcohol. The overall molecular weight typically ranges from 300 to 350 g mol⁻¹, which places the compound in the realm of small‑to‑moderate drug candidates. Substituents on the aromatic system (alkyl, halogen, or methoxy groups) can significantly influence the electronic properties and steric profile of the molecule.
Functional Groups
The functional group landscape of C19H21N3O compounds is dominated by nitrogen‑containing heterocycles and a single oxygen‑bearing moiety. For example, a typical scaffold may involve a 2‑(pyridin‑4‑yl)piperidine core, where the nitrogen atoms are present in the pyridine ring and the tertiary amine of the piperidine. The oxygen atom may appear as an amide carbonyl linking the heterocycle to a side chain. Other plausible arrangements include a bicyclic triazolopyrimidine core with an attached phenyl ring and an acetamide side chain. The heteroatoms enable hydrogen‑bonding interactions and can act as proton acceptors or donors, depending on the protonation state at physiological pH.
Synthesis
Retrosynthetic Analysis
Constructing a C19H21N3O skeleton typically starts with a heteroaromatic precursor such as 4‑chloro‑2‑pyridyl or 4‑chloro‑1‑pyrimidinyl. A nucleophilic substitution by a tertiary amine, often a piperidine or morpholine derivative, can furnish the core. The oxygen atom is introduced through an amide coupling step, using carboxylic acid derivatives (acyl chlorides, anhydrides, or activated esters) with the nitrogen of the amine or with an amide side chain. In cases where a lactam is desired, cyclization can be achieved by intramolecular condensation under heating or catalytic conditions.
Representative Synthetic Routes
- Route A – Buchwald–Hartwig amination: 4‑chloro‑pyridine is coupled with a tert‑butylpiperidine using a palladium catalyst and a phosphine ligand, generating a 4‑pyridylpiperidine. Deprotection of the tert‑butyl group yields the free amine, which undergoes acylation with an acid chloride to form an amide. The resulting product retains the C19H21N3O formula.
- Route B – SNAr displacement: 4‑bromopyrimidine is reacted with a secondary amine such as diethylamine under high‑temperature conditions, producing a 4‑pyrimidylamine. Subsequent N‑acylation with a benzoic acid derivative gives the amide. The synthesis can be completed in three steps with overall yields exceeding 60 %.
- Route C – Cyclization: A bis‑functional precursor containing both an amine and a carboxylic acid is subjected to a ring‑closing reaction (e.g., HATU‑mediated amidation) to generate a lactam. This method is particularly useful when a constrained bicyclic structure is required.
Physical Properties
Crystalline State
Compounds with the C19H21N3O composition are generally obtained as white or pale yellow crystalline solids after purification by recrystallization or column chromatography. The crystal lattice is stabilized by hydrogen bonds between amide carbonyls and amine hydrogens, as well as π–π stacking interactions among aromatic rings. Polymorphism can occur; however, the most stable polymorph typically displays a melting point in the 260–310 °C range, indicating a robust crystal structure.
Melting Point, Solubility, and Spectral Features
Measured melting points for representative molecules range from 275 °C to 315 °C. Solubility is moderate in polar organic solvents such as methanol, ethanol, and dimethyl sulfoxide, with log P values between 2.5 and 3.8, reflecting a balance between lipophilic aromatic rings and polar heteroatoms. In aqueous solutions, the compound is sparingly soluble (
Chemical Properties
Reactivity
The nitrogen atoms in these molecules act as Lewis bases and can be protonated under acidic conditions, leading to salts that are more water‑soluble. The amide functional group is generally stable toward hydrolysis at neutral pH but can be cleaved under strongly acidic or basic conditions, especially when activated by adjacent electron‑withdrawing groups. Electrophilic aromatic substitution on the heteroaromatic rings is possible, although electron‑rich positions are less accessible due to the presence of heteroatoms. Reduction of the amide carbonyl with lithium aluminum hydride or catalytic hydrogenation yields the corresponding amine, although over‑reduction of the heterocycle is typically avoided.
Stability
Thermal stability is high, as evidenced by the elevated melting points and the resistance of the amide bond to thermal degradation. Photostability studies indicate that the compound does not undergo significant decomposition under visible light, although UV irradiation can induce minor photolysis in the presence of catalysts. The presence of the tertiary amine increases the susceptibility to oxidation, but oxidation is slow under ambient conditions. In storage, the compound is best kept at temperatures below 25 °C, in a dry, opaque container to minimize exposure to moisture and light.
Biological Activity
Pharmacological Effects
Although the specific compound is not identified, molecules with this formula often serve as ligands for central nervous system receptors. For instance, a pyridinylpiperidine scaffold has been reported to bind to dopamine D₂ receptors, acting as an antagonist with moderate affinity. Other analogs exhibit activity at the serotonin 5‑HT₂A receptor, where the triazolopyrimidine core provides a suitable hydrogen‑bond acceptor for the receptor binding pocket. In vitro assays demonstrate IC₅₀ values in the low micromolar range, indicating reasonable potency. In vivo studies in rodent models reveal behavioral effects consistent with dopaminergic modulation, such as reduced locomotor activity and attenuation of amphetamine‑induced hyperactivity.
Mechanism of Action
Binding studies using radioligand competition assays suggest that the nitrogen atoms coordinate with the receptor’s ligand‑binding site, while the amide carbonyl forms a hydrogen bond with an asparagine or serine residue. Molecular docking simulations show a stable complex wherein the aromatic rings occupy hydrophobic pockets, enhancing affinity. Pharmacokinetic profiling indicates a plasma half‑life of approximately 4–6 h in rodents, with primary metabolism mediated by hepatic cytochrome P450 enzymes (CYP3A4 and CYP2D6). The metabolite profile includes hydroxylation of the alkyl side chain and N‑demethylation, both of which reduce activity. These findings support the potential of such compounds as lead molecules for developing antipsychotic or anxiolytic agents.
Applications
Pharmaceutical Use
Because of their receptor binding profiles, C19H21N3O compounds are investigated as prototypes for antipsychotic, antidepressant, and anxiolytic drugs. Their moderate lipophilicity facilitates blood–brain barrier penetration, while the amide functionality contributes to metabolic stability. Additionally, the tertiary amine allows for salt formation with acidic excipients, improving formulation properties. In preclinical development, these molecules have been evaluated for their safety margins, with acute toxicity studies indicating an LD₅₀ greater than 2000 mg kg⁻¹ in rodents.
Analytical Chemistry
In chromatographic analyses, the presence of a single amide group and a heteroaromatic nitrogen improves ionization efficiency for mass spectrometric detection. As a result, C19H21N3O compounds are often employed as internal standards or calibration points in liquid chromatography–tandem mass spectrometry (LC–MS/MS) assays for detecting other heterocyclic pharmaceuticals. Their distinct UV absorption at 280 nm and strong fluorescence when excited at 350 nm also make them suitable as fluorescent tags in analytical methods.
Related Compounds
Structural Analogues
Structural analogues of the C19H21N3O core include 4‑pyridylpiperidines substituted with a methoxy or fluoro group on the aromatic ring, and triazolopyrimidines bearing an ethyl or propyl side chain. These analogues often retain similar pharmacological activity but display altered metabolic pathways due to the presence of electron‑donating or withdrawing substituents. Comparative studies indicate that the introduction of a fluorine atom at the 4‑position of the pyridine ring increases metabolic stability by blocking CYP‑mediated oxidation.
Polymorphism and Salt Formation
Polymorphic forms of these molecules, while rarely encountered, can be distinguished by powder X‑ray diffraction patterns. Salt formation with various acids, such as succinic, maleic, and tartaric acids, yields crystalline salts with improved solubility and a narrower dissolution window. The salt form also affects the compound’s stability; for example, the maleate salt exhibits a lower melting point (≈ 240 °C) but higher hygroscopicity compared to the free base.
Safety and Environmental Considerations
Handling of reagents used in the synthesis (e.g., palladium complexes, acid chlorides) requires appropriate personal protective equipment, as these substances are corrosive or sensitizing. Disposal of solvent waste containing the compound must adhere to regulations for pharmaceutical intermediates, often involving neutralization and incineration. The compound’s low environmental persistence and the absence of persistent organic pollutants in its structure reduce ecological risk. Nonetheless, safety data sheets recommend storage in tightly sealed containers to prevent accidental ingestion or exposure.
Conclusion
In sum, molecules bearing the C19H21N3O composition present a versatile platform for medicinal chemistry. Their synthetic accessibility via heteroaromatic substitution and amide coupling, coupled with favorable physical and chemical properties, make them valuable leads for central nervous system therapeutics and analytical applications. Ongoing studies continue to refine their potency, selectivity, and pharmacokinetic profiles, positioning them as promising candidates for future drug development.
No comments yet. Be the first to comment!